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The rotavirus inner capsid protein VP6 contains conserved epitopes that are potential targets for eliciting protective
immunity against different serotypes within the same group of rotavirus. In order to determine whether VP6 alone can
induce protective immunity, an expression vector pcDNA1/EDIM6 containing gene 6 of rotavirus EDIM strain was constructed
and used as a vaccine in an adult mouse model. Cloned gene 6 was determined to be 1356 nucleotides long and contained
a 5* noncoding region of 23 nucleotides, a 3* noncoding region of 139 nucleotides, and a coding frame of 1194 nucleotides
for a polypeptide of 397 amino acid residues. Recombinant VP6 was expressed in rabbit reticulocyte lysate and the heat-
denatured recombinant VP6 migrated in SDS-gels with an apparent molecular weight of approximately 43 kDa. Five additional
polypeptide bands corresponding to oligomers of recombinant VP6 were observed when the expressed product was not
heat denatured. To determine the immunogenicity of recombinant VP6, female BALB/c mice were injected intramuscularly
or intradermally with pcDNA1/EDIM6, or were inoculated epidermally with plasmid-coated gold beads using the Geniva
Accell particle delivery device. Only intradermal injection and particle delivery elicited measurable serum anti-rotavirus IgG
responses, but responses developed following particle delivery were significantly (P  0.001) greater. However, none of the
delivery methods induced serum or stool anti-rotavirus IgA responses and, when challenged with EDIM no protection against
infection was observed in the immunized mice. Therefore, parenteral immunization with VP6 alone elicited large anti-rotavirus
IgG responses but did not elicit protection against murine rotavirus infection in this model. q 1997 Academic Press
INTRODUCTION McNeal et al., 1992). Instead, protection has been found
to correlate with titers of serum and stool anti-rotavirus
Rotaviruses are the single most important cause of
IgA (McNeal et al., 1994; Feng et al., 1994), both of which
severe infantile viral gastroenteritis. Vaccination remains
remained elevated for at least 14 months after oral immu-
to be the most feasible means of controlling rotavirus-
nization (McNeal and Ward, 1995). Recently, it was con-
induced diarrhea. The rotavirus vaccines that have been
firmed, using B cell-deficient mice, that maintenance of
evaluated to date are live attenuated virus vaccines de-
active immunity against rotavirus infection in mice was
rived from bovine or simian strains and are delivered
dependent on the presence of antibody (McNeal et al.,
orally to mimic protection following natural infection.
1995; Franco and Greenberg, 1995). Although CD8/ cells
However, these vaccines have been shown to be only
appear to play little role in long-term protection in mice,
partially protective (De-Mol et al., 1986; Christy et al., these cytotoxic T lymphocytes were found to be critical
1988; Bernstein et al., 1991; Santosham et al., 1991; Bern- for resolution of rotavirus infection in B cell-deficient JHDstein et al., 1995; Clark et al., 1996; Kapikian et al., 1996). mice (McNeal et al., 1995; Franco and Greenberg, 1995).
The mechanism of protection by vaccines or natural in- Very recent evidence with immunocompetent BALB/c
fection is unclear. There is evidence provided by a num- mice, however, indicated that resolution of rotavirus
ber of studies to indicate that human serum or intestinal shedding was due to the combined effects of CD8/ cells
rotavirus antibody titers correlate with protection (Kapi- and CD4/ cell-dependent antibody production (McNeal
kian et al., 1983; Ryder et al., 1985; Chiba et al., 1986; et al., submitted). Thus, both arms of the immune system
Ward et al., 1989; Clemens et al., 1992; O’Ryan et al., were involved in rotavirus immunity in mice.
1994), although in other studies no correlation between The inner capsid protein VP6 of rotavirus carries
protection and anti-rotavirus antibody was observed group-specific antigens (Greenberg, 1983; Lambert et al.,
(Ward and Bernstein, 1995). In studies using mice, no 1984; Gorziglia et al., 1988; Gerna et al., 1989; Lopez and
association between protection and serotype-specific Arias, 1994) as well as CTL epitopes which could be
neutralizing antibody has been found (Ward et al., 1992; important in cell-mediated immunity (Franco et al., 1994;
Offit et al., 1994). Although VP6 does not elicit neutralizing
antibodies (Lambert et al., 1984; Hoshino et al., 1987;1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (513) 636-7655. E-mail: achoi@chmcc.org. Gerna et al., 1989; Poncet et al., 1990), a recent study
129
0042-6822/97 $25.00
Copyright q 1997 by Academic Press
All rights of reproduction in any form reserved.
AID VY 8552 / 6a36$$$121 04-29-97 03:21:57 viras AP: Virology
130 CHOI ET AL.
using a hybridoma backpack model in mice has revealed RT/PCR
that nonneutralizing monoclonal anti-VP6 IgA secreted
To generate ds (double-stranded) cDNA of gene 6 ofby injected hybridoma cells is protective (Burns et al.,
rotavirus strain EDIM by reverse transcription/polymer-1996). The mechanism of protection has been speculated
ase chain reaction (RT/PCR), 1 mg of purified ds rotavirusto involve intracellular inactivation of rotavirus by anti-
RNA was denatured (3 min, 947) in 10 ml of distilled waterVP6 IgA. Thus, VP6 is a potential candidate of rotavirus
containing 10% DMSO, 150 ng of a forward primer (5*subunit vaccine which may elicit long-term protective im-
GGC TTT TAA ACG AAG TCT TC), and 150 ng of a reversemunity.
primer (5* GGT CAC ATC CTC TCA CT). The primersUsing an adult mouse model, we have previously
used were based on the terminal sequences of the 5*shown that parenteral immunization with inactivated ro-
and 3* noncoding regions (NCR) of gene 6 of rotavirustavirus leads to protection (McNeal et al., 1992), a result
strain SA-11 and other group A rotaviruses. The primersalso found with immunized rabbits (Conner et al., 1993).
were allowed to rapidly anneal to denatured viral RNASince the rotavirus proteins that are responsible for pro-
by cooling the suspension on ice. Forty microliters of RT/tection have not been identified, we sought to determine
PCR reaction mixture [50 mM Tris (pH 8.3), 75 mM KCl,the protective efficacy of individual proteins by using the
15 mM DTT, 15 mM MgCl2 , 100 mg/ml BSA, 1 mM dNTP,method of DNA-based immunization. In this report, ex-
16.5 U of RNasin ribonuclease inhibitor (Promega), 16 Uperiments were performed to determine whether paren-
of Moloney murine leukemia virus reverse transcriptaseteral immunization of mice with a vector expressing pro-
(Life Technologies), and 5 U of Taq polymerase (Perkin –tein VP6 of murine EDIM strain of rotavirus alone would
Elmer)] were then added. Reverse transcription was car-elicit immune responses that could lead to protection.
ried out at 377 for 2 hr and immediately followed by 30
cycles (1 min, 947; 2 min, 557; and 1.5 min, 727) of PCR.
MATERIALS AND METHODS
After the last cycle, a final extension step (10 min, 727)
was included.Virus
The murine EDIM strain of rotavirus used in this study
Construction of recombinant plasmid
was originally isolated from the stool of an infected
mouse and adapted to grow in cell culture by passage Standard cloning procedures were carried out (Ausu-
in MA-104 cells (Ward et al., 1990). A viral lysate of the bel et al., 1995). ds cDNA generated by RT/PCR were
ninth passage was used to challenge mice and a triply cloned into the SmaI site of the lacZ gene of pGEM-3Z
plaque-purified isolate of this passage was used to infect (Promega) by blunt end ligation. Ligation products were
MA-104 cells to yield stock virus for RNA purification. then transformed into Escherichia coli strain JM109.
White transformants carrying recombinant plasmids
Purification of virus RNA were selected by growing cells on LB agar plates con-
taining IPTG (0.5 mM) and X-gal (40 mg/ml, Life Technolo-
MA-104 cells were infected with rotavirus as described gies). Plasmids from individual colonies were purified by
previously (Ward et al., 1990). When cytopathic effect
alkaline lysis and analyzed on agarose gels. Recombi-
was observed, Triton X-100 was added directly to the
nant plasmids with sizes corresponding to that con-
infected cells to a final concentration of 1%. After incu-
taining gene 6 were further analyzed by nucleotide se-
bating for 30 min at room temperature, insoluble cell
quencing.
debris was removed by centrifugation (2,000 rpm, 30
min, 47) and the resulting supernatant was further centri-
fuged (20,000 rpm, 90 min, 47) to pellet the virions. The Nucleotide sequencing
crude virus pellet was resuspended in TE buffer (10 mM
To establish that the plasmids in fact contained EDIMTris, pH 7.5, 1 mM EDTA). Ten volumes (vol) of TRIZOL
gene 6 and to determine the orientation of the insert,(Life Technologies) was added to the virus suspension
plasmids purified from two randomly picked coloniesand vortexed briefly. After 5 min, 0.2 vol of chloroform
were sequenced in both directions using SP6 and T7was added and shaken vigorously for 15 sec. The extract
sequencing primers. Nucleotide sequencing was carriedwas spun in a microcentrifuge to separate the aqueous
out using the Circum Vent Thermal Cycle DNA Sequenc-and organic phase (12,000 g, 15 min, 47). Isopropanol
ing kit (NEB) and [a-35S]dATP or using the Silver Se-was then added to the aqueous phase and the sample
quencing System (Promega) according to the protocols ofwas incubated at room temperature for 10 min. Viral
the suppliers. The nucleotide sequence data have beenRNA was pelleted by centrifugation (12,000 g, 10 min, 47),
submitted to the GenBank database and have been as-washed with 75% ethanol, air dried, and resuspended in
nuclease-free H2O. signed the Accession No. U65988.
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Construction of the VP6 expression vector boosted 2 times at 4 and 6 weeks following primary
inoculation. Immunized animals were challenged with anpcDNA1/EDIM6
oral dose of 4 1 104 ffu of EDIM virus given at 14 days
The mammalian expression vector pcDNA1/EDIM6 after the last immunization.
was constructed by subcloning gene 6 from pGEM-3Z/
EDIM6 into the restriction sites BamHI and EcoRI of Measurement of anti-rotavirus antibody titers
pcDNA1 (Invitrogen), placing the entire gene 6 under the Blood specimens were collected on the day when mice
control of T7 promoter and human CMV IE (immediate- were immunized or challenged, and at Day 21 after chal-
early) promoter and the SV40 polyadenylation signal/in- lenge. Titers of serum VP6 or anti-rotavirus IgG and IgA,
tron sequence. and stool IgA, were measured essentially as previously
described (McNeal et al., 1994). Ninety-six-well plates
In vitro expression of VP6 were coated with rabbit anti-EDIM rotavirus IgG, followed
by addition of an EDIM rotavirus lysate or a mock-in-The TNT Coupled Transcription/Translation System,
fected cell lysate. Serial twofold dilutions of pooled serawhich contains rabbit reticulocyte lysate (Promega), was
from EDIM-infected mice (serum standards) assignedused to establish that recombinant VP6 can be ex-
concentrations of 160,000 or 10,000 U/ml of anti-rotaviruspressed in vitro. A 50-ml reaction mixture consisted of 25
IgG or IgA, respectively, were made and added to dupli-ml of rabbit reticulocyte lysate, T7 polymerase, 20 mM
cate wells coated with EDIM rotavirus or cell lysate toamino acid mixture minus methionine, 0.8 mCi of [35S]-
generate a standard curve. Appropriate dilutions ofmethionine (Amersham), 0.8 U of RNasin ribonuclease
mouse sera to be tested were also added to duplicateinhibitor (Promega), and 1 mg of pcDNA1/EDIM6. Cou-
wells containing virus or cell lysate. This was followedpled transcription and translation was carried out at 307
by sequential addition of biotin-conjugated goat anti-for 90 min according to the instruction of the supplier.
mouse IgG or IgA, peroxidase-conjugated avidin-biotin,Gel loading buffer (50 mM Tris, pH 6.8, 10% glycerol, 2%
and substrate (O-phenylenediamine and H2O2). Color de-SDS, 0.005% bromophenol blue) was added to reticulo-
velopment was stopped with 1 M H2SO4 and A490 wascyte lysate which was either incubated at 377 for 30 min
measured. The concentration (units/ml) of anti-rotavirusor boiled for 5 min and then subjected to electrophoresis
IgG or IgA were determined from a plot of the standardat 47 in 10% SDS–polyacrylamide gels.
antisera after subtraction of the average A490 values of
duplicate wells coated with cell lysate from those coatedMice
with EDIM lysate.
Female BALB/c mice 6 weeks of age (Harlan –
Measurement of neutralizing antibodySpraque–Dawley) were housed in groups of four in ster-
ile microisolation cages. All procedures were conducted Measurement of neutralizing antibody to EDIM was
in accordance with protocols reviewed and approved by performed by an antigen reduction assay as previously
the Children’s Hospital Research Foundation Institutional described using the triply plaque-purified EDIM isolate
Animal Care and Use Committee. (Knowlton et al., 1991).
Detection of rotavirus sheddingImmunization of mice with pcDNA1/EDIM6
Stools (two pellets) were collected into 0.5 ml of EBSSpcDNA1/EDIM6 was purified from E. coli by alkaline
on the day of EDIM rotavirus challenge and for 10 dayslysis and using pZ523 columns (5 Prime To 3 Prime).
following challenge. Stool pellets collected in EBSS werePurified plasmids were suspended at 1 mg/ml of 150 mM
stored frozen (0207) then homogenized and centrifugedNaCl. A group of two mice was immunized intramuscu-
(1,500 g, 5 min, 47) to remove debris before being ana-larly using a 1-ml syringe and a 28-gauge needle into
lyzed. Shedding of rotavirus antigens was determinedthe muscles of the hind leg with 100 mg of plasmids (50
by ELISA as previously described (McNeal et al., 1994).mg bilaterally). Animals were boosted twice at 2-week
Quantity of rotavirus in units/ml was determined from aintervals. For intradermal injections, a second group of
standard curve using an EDIM-infected cell lysate whichfour mice was injected using a 28-gauge needle with a
was arbitrarily assigned a concentration of 10,000 anti-total of 100 mg of DNA in 300 ml of saline at three sites
gen units/ml.1–2 cm distal from the base of the tail and were boosted
3 times at 4, 8, and 16 weeks following primary inocula- RESULTS
tion. A third group of four mice was inoculated at two
Nucleotide and amino acid sequence analyses ofadjacent sites in the abdomen with a total of 0.5 mg of
rotavirus EDIM gene 6gold particles coated with 2 mg of pcDNA1/EDIM6 using
the Accell particle delivery device (Geniva) according to To isolate rotavirus EDIM gene 6 encoding the inner
capsid protein VP6, genomic RNA segments were puri-the instructions of manufacturer. The animals were
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FIG. 1. Amino acid sequence of EDIM rotavirus VP6. The deduced amino acid sequence of EDIM rotavirus VP6 (GenBank database Accession
No. U65988) is compared with that of murine strain EW (Accession No. U36474). The sequence is shown for EDIM only and the five differences in
EW are indicated by single amino acid codes.
fied and used as templates for RT/PCR. The RT/PCR five oligomers having apparent molecular sizes of 86, 94,
111, 129, and 158 kDa (Fig. 2A). When the samples wereproduct was analyzed in an agarose gel. A band of DNA
having about 2.3 kbp that corresponds to the expected heated (5 min, 957) and analyzed by SDS–PAGE, these
oligomers dissociated into VP6 monomers (Fig. 2B).size of gene 6 was excised from the gel, purified, and
cloned into the SmaI site of pGEM-3Z to create pGEM- Background polypeptides that were apparently synthe-
sized from pcDNA1/Amp (indicated by l) and internal3Z/EDIM6. DNA sequencing was performed to ascertain
that the 2.3-kbp insert was gene 6. Plasmids from two
independent bacterial clones were purified and se-
quenced in both directions and the sequences generated
were found to be identical. The nucleotide sequence for
EDIM was determined to be 1356 nucleotides long con-
sisting of an open reading frame of 1194 nucleotides
that encoded a polypeptide of 397 amino acids, a 5*
noncoding region of 23 nucleotides and 3* noncoding
region of 139 nucleotides, the same as that reported for
the murine strain EW in GenBank. Since the progenitor
murine rotavirus strain for EDIM was the same as that
of EW (Kraft, 1957), the two strains were expected to
have nearly identical VP6 gene sequences. With the ex-
ception of five residues, the deduced amino acid se-
quence of the EDIM VP6 protein was identical to that of
EW (Fig. 1).
Expression of recombinant proteins in vitro
The gene 6 insert was subcloned from pGEM-3Z/
EDIM6 into the eukaryotic expression vector pcDNA1/
Amp placing gene 6 under the control of the CMV IE
FIG. 2. In vitro expression of EDIM VP6. Recombinant VP6 waspromoter and SV40 polyadenylation/intron sequences to
expressed and labeled with [35S]methionine using a coupled tran-create pcDNA1/EDIM6 for immunization. To ensure that
scription/translation rabbit reticulocyte lysate system as described
the subcloned gene 6 could express VP6 in vitro, under Materials and Methods. Samples containing translated pep-
pcDNA1/EDIM6 was used as a template in the TNT Cou- tides were heated for 30 min at 377 (A) or for boiled for 5 min (B)
before analyses by SDS – PAGE. Lanes 1, pcDNA1/Amp used as tem-pled Transcription/Translation System using the phage
plate. Lanes 2, pcDNA1/EDIM6 used as template. The small arrow-T7 DNA polymerase for transcription, and [35S]methi-
heads indicate oligomeric VP6, the large arrowhead indicates VP6onine for peptide labeling. Synthesized polypeptides
monomers, the symbol l indicates background polypeptides synthe-
were analyzed by SDS–PAGE. Under nondenaturing con- sized from pcDNA1/EDIM6 and the symbol l indicates background
ditions (30 min, 377), VP6 could be observed as a mono- polypeptides synthesized from pcDNA1. Molecular weight markers
are indicated in kDa.mer of approximately 43 kDa and as a panel of at least
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TABLE 1
Serum Anti-rotavirus IgG in BALB/c Mice Immunized with pcDNA1/6 Using the Gene Gun or Intradermal Inoculation
Serum IgG (U/ml)
Route of Mouse
immunization number Preimmune Postdose 1 Postdose 2 Postdose 3 Postdose 4
None 1 100a 100 100 100 N.A.b
2 100 100 100 100 N.A.
3 100 100 100 100 N.A.
4 100 100 100 100 N.A.
Gene gun 1 100 579 215,019 402,899 N.A.
2 100 5,156 118,126 333,439 N.A.
3 100 2,795 235,393 372,526 N.A.
4 100 143 27,739 86,536 N.A.
Intradermal 1 100 100 100 100 100
2 100 100 677 52,759 68,889
3 100 100 100 1,339 1,104
4 100 100 100 100 100
a Titers of 100 U/ml indicate that no anti-rotavirus IgG was detected.
b N.A., Not administered.
reading frames of gene 6 in pcDNA1/EDIM6 (indicated nized mice as well as in the control group and continued
through Days 7–8 (Table 3). The quantity of virus shedby l) were also observed.
during Days 3 and 4 by mice injected with the gene gun
was significantly lower than that of the control group (PImmunization of mice with pcDNA1/EDIM6
 0.05; Student’s t test). This difference was probably an
To determine whether expressed recombinant pro- artifact due to the small number of mice in this experi-
teins were immunogenic, BALB/c mice were first immu-
nized intramuscularly with pcDNA1/EDIM6 at two sites
(100 mg/dose, 3 doses) in the hind limb at biweekly inter- TABLE 2
vals. Two weeks after the last immunization, no serum
GMTs of Anti-rotavirus Antibody in Immunized and Control Mice
anti-rotavirus IgG could be detected by ELISA (results before and after EDIM Challenge
not shown). We next attempted to induce immune re-
GMT of anti-rotavirus antibody (U/ml)asponses to VP6 by gene gun immunization at two sites
Anti-(2 mg/dose, 3 doses) or by intradermal inoculation of
rotavirus Route ofpcDNA1/EDIM6 at three sites (100 mg/dose, 4 doses).
antibody immunization Post-vaccinationb Post-challengec
Serum anti-rotavirus IgG titers increased steadily in all
mice following gene gun inoculation (Table 1) and the Serum IgG None 100 65,772 { 1,597
Gene gun 254,278 { 63,151 3,667,514 { 895,164dfinal titers were similar to those found following paren-
Intradermal 660 { 17,124 130,836 { 47,609e,fteral immunization with live EDIM (McNeal et al., 1992).
Serum IgA None 100 6,516 { 570Intradermal inoculation resulted in moderate serum anti-
Gene gun 100 2,613 { 443g
rotavirus IgG titers in two of four mice. The other two Intradermal 100 2,477 { 1,184
mice did not seroconvert. Serum and fecal IgA titers were Fecal IgA None 5 3,645 { 1,048
Gene gun 5 2,230 { 777also analyzed by ELISA but no rotavirus-specific IgA was
Intradermal 5 814 { 610detected in mice immunized by either intradermal or
gene gun inoculation (Table 2). Furthermore, none devel- a Antibody titers are expressed as GMT (geometric mean) { SE
oped neutralizing antibody to EDIM (results not shown). (standard error).
b Blood and stool specimens were collected on the day when mice
were challenged with EDIM rotavirus.Lack of protection in vaccine DNA immunized mice
c Specimens were collected at 21 days after mice were challengedagainst EDIM
with EDIM rotavirus.
d Significantly (P  0.001) greater than control group.Mice inoculated with the gene gun or immunized intra-
e The 2 mice that did not have anti-rotavirus IgG responses followingdermally were orally challenged at 14 days after the last
vaccination had titers of 94,690 and 94,304 following challenge, not
immunization using live EDIM virus to determine whether significantly greater than the titers of control mice.
they were protected from infection. Shedding of rotavirus f Significantly (P  0.04) greater than control group.
g Significantly (P  0.02) less than control group.began on Day 2 after challenge in both groups of immu-
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TABLE 3
Rotavirus Shedding Following Challenge of Mice Immunized with pcDNA1/EDIM6 Using the Gene Gun or Intradermal Inoculation
GMT (U/ml)a
Route of
immunization Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9
None 4 { 10 598 { 1,071 974 { 183 840 { 172 279 { 35 45 { 35 4 { 11 2
(4b –31)c (56–4,727) (731–1,552) (562–1,209) (214–348) (8–171) (4–45) (4)
Gene gun 7 { 80 28 { 301d 48 { 82e 586 { 1,309 124 { 101 34 { 288 8 { 69 2
(4–320) (4–1,242) (4–375) (78–5,606) (15–488) (4–1,059) (4–198) (4)
Intradermal 28 { 239 2,400 { 1,209 875 { 536 879 { 1,585 506 { 820 35 { 39 2 2
(4–987) (864–6,513) (314–2,639) (108–5,945) (74–3,613) (4–178) (4) (4)
a GMT of shed rotavirus in U (antigen units)/ml { SE.
b Titers of 4 U/ml indicate that no shedding was detected. A value of 2 was used for calculation.
c Ranges of rotavirus shedding are shown in parenthesis.
d Significantly (P  0.04) less than intradermally inoculated mice.
e Significantly (P £ 0.05) less than unimmunized or intradermally inoculated mice.
ment. When the experiment was repeated with six mice/ -388 coded for lys, leu, val, and val, respectively, in EDIM;
while asn, val, ala, and asp were found in these positionsgroup, very similar rotavirus IgG titers were obtained in
mice immunized following gene gun inoculation of the in EW. However, it is noteworthy that these four EDIM
residues were identical to those in the correspondingVP6 gene but shedding following EDIM challenge paral-
leled that of the unimmunized controls (results not positions in the VP6 sequence of the simian group A
rotavirus strain SA-11.shown). Therefore, evidence of protection against shed-
ding was absent following immunization with the VP6 SDS–PAGE analyses of polypeptides synthesized
from the recombinant VP6 plasmids in rabbit reticulocytegene by either route. In agreement with the shedding
lysate revealed the presence of at least five oligomericpattern, mice in each group had large increases in serum
forms of a peptide that could be heat dissociated intoanti-rotavirus IgG and IgA as well as stool anti-rotavirus
monomers having the anticipated mass of about 43 kDaIgA following EDIM challenge (Table 2). The geometric
of VP6. Based on the distances migrated, two oligomersmean titer of serum anti-rotavirus IgG in the immunized
having estimated sizes of 86- and 129-kDa oligomersgroups were, however, significantly greater (P  0.001
appeared to be the dimeric and trimeric forms of VP6.or 0.04; Student’s t test) than that of the control group
The propensity for VP6 to remain associated in polyacryl-following challenge while the GMT of serum anti-rotavi-
amide gels as trimers (Gorziglia et al., 1985; Estes et al.,rus IgA for the gene gun immunized mice was signifi-
1987; Lopez et al., 1994) and possibly dimers (Mackowcantly less (P  0.02) than that of the control animals. A
et al., 1993) has been previously observed when VP6 waslikely explanation for the latter observation was that anti-
analyzed under partial denaturing conditions. In addition,rotavirus IgA had to compete in the ELISA with much
other VP6 oligomers have also been reported by Mackowhigher quantities of anti-rotavirus IgG in the gene gun-
et al. (1993) who suggested that these oligomers mayimmunized mice than in control mice, thus potentially
represent conformational intermediates of VP6 dimersreducing its measurable titer.
and trimers. Thus, the other three oligomers having ap-
parent molecular sizes of 94, 111, and 158 kDa mayDISCUSSION
depict dimer and trimer intermediates. Alternatively,
In this study, we constructed a vector, pcDNA1/EDIM6, these five oligomers may in fact correspond to VP6 di-
that contains gene 6 encoding VP6 of murine rotavirus mers, trimers, tetramers, pentamers, and hexamers since
strain EDIM, and used this vector for DNA-based immuni- they were observed to be separated by uniform distances
zation in a mouse model developed for studies of active from each other, an observation that has not been pre-
immunity (Ward et al., 1990). The amino acid sequence viously documented. The progression in sizes (i.e., 86,
was deduced from the nucleotide sequence of pcDNA1/ 94, 111, 129, and 158 kDa) of these oligomers, however,
EDIM6 and compared with that of the group A rotavirus did not correspond to discrete increments of 43 kDa for
strain EW, which had the same origin as the EDIM strain each inclusion of VP6 into the successive oligomers. This
used in this study (Kraft, 1957). Both sequences code for enigma can be explained by the fact that the oligomers
a polypeptide containing 397 amino acid residues, 392 were only subjected to mild denaturation conditions
of which were found to be identical. Of the five amino which permitted the oligomers to retain structural confor-
mations that would account for their faster migration be-acid residues that were different, aa-118, -119, -237, and
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havior. Consequently, their deduced molecular weights lysis. Muscle cells do not normally present antigens
since they appear to express only a small number ofwere inaccurate since they were based on the migration
distances of molecular weight markers that were com- MHC class I and no MHC class II molecules (Hohfeld and
Engel, 1994; Ertl et al., 1995). Thus, the role of transfectedpletely denatured.
Expression of recombinant VP6 in immunized female muscle cells in DNA-based immunization remains un-
clear. Following release, antigens are thought to be takenBALB/c mice following inoculation by three different
routes was determined by measurement of anti-rotavirus up by professional APC, especially dendritic cells (Ba-
biuk et al., 1995; Whalen et al., 1995; Ertl et al., 1995;IgG by ELISA. From the titers of IgG, gene gun inoculation
was found to be very efficient while intradermal injection Condon et al., 1996), which process and present antigens
to CD4/ T cells in the draining lymph nodes (Larsen etwas less effective and intramuscular injection stimulated
no detectable anti-rotavirus IgG. Following gene gun in- al., 1994). The skin is known to be rich in skin-associated
lymphoid tissues (SALT), which comprise Langerhans’oculation, anti-rotavirus IgG responses were induced in
all mice while only two of four animals injected intrader- cells (MHC II), dendritic cells (MHC II), keratinocytes
(MHC I and II), and other cells of the immune systemmally seroconverted. In addition, earlier and substantially
larger responses were detected in mice inoculated with (Memar et al., 1995), while the muscle contains very few
if any lymphoid cells (Raz et al., 1994). The absence orthe gene gun than with intradermal injection. An IgG
response was observed after gene gun inoculation with low abundance of APC in the muscle and the ineptness
of muscle cells to present antigen appear to explain thea single 2-mg dose of DNA while at least two 100-mg
doses were required by intradermal injection to induce lack of humoral responses in this study. In order to ex-
plain reports of induction of immune responses by intra-a response. Mice inoculated intramuscularly with three
100-mg doses, on the other hand, did not respond. These muscular immunization, it was suggested that leaking of
DNA occurs during intramuscular injection (Raz et al.,results support the notion that intradermal injection is
superior to intramuscular injection and that gene gun 1994). This inadvertently exposes the SALT to injected
DNA leading to the observed immunity.inoculation is the most efficient method for immunization
both in terms of the quantity of DNA required and the Oral inoculation of mice with different strains of animal
rotaviruses has been found to induce rotavirus-specificmagnitude of the immune responses (Fynan et al., 1993;
Ras et al., 1994; Johnston et al., 1994; Ertl et al., 1995). IgA as well as IgG. Following primary infection with some
but not all animal rotaviruses, mice acquired protectiveLittle is known regarding the mechanisms by which
DNA-based immunization induces humoral responses. immunity against subsequent murine rotavirus infection
and it was found that anti-rotavirus IgA titers but notTherefore, it is unclear what factors contribute to the
different VP6-specific IgG responses that were generated IgG titers correlated with protection (McNeal et al., 1994;
Feng et al., 1994). Furthermore, primary infection withfollowing gene gun, intradermal, or intramuscular inocu-
lation. One may speculate that the response generated murine rotavirus strain EDIM resulted in protection
against reinfection for at least 14 months and titers ofby a particular route is a function of the number and the
type of cells amenable to transfection as well as antigen anti-rotavirus IgA and IgG remained elevated during that
period (McNeal and Ward, 1995). Whether protection fol-processing and presentation. The area of epidermis that
received DNA was estimated from the circular reddish lowing parenteral immunization could also be correlated
with titers of IgA or was more related with IgG titers wascoloration imparted on a piece of parafilm generated by
gold particle bombardment to be approximately 3.5 cm2. recently examined. Intraperitoneal (ip) immunization of
mice with either inactivated (McNeal et al., 1996) or liveThe area of the blebs resulted from intradermal injection
could not be measured accurately but was estimated to (unpublished results) EDIM generated high titers of anti-
rotavirus IgG but little if any anti-rotavirus IgA. Even so,be less than 1 cm2. In the case of intramuscular injection,
the interstitial space in the muscle is limited. Therefore, ip-immunized animals were almost completely protected
against subsequent EDIM infection. This suggested thatthe area of quadriceps muscles exposed to injected DNA
is considered to be smaller than the areas determined an immune mechanism other than that involving anti-
rotavirus IgA can be responsible for protection. Measure-for epidermal and intradermal immunization. It then
stands to reason that the exposure of tissues to DNA is ment of serum and fecal anti-rotavirus IgA was performed
following vaccination with pcDNA1/EDIM6 but neithertheoretically greatest for gene gun, followed by intrader-
mal and then intramuscular inoculation. At the inocula- was detected in the postimmunization sera, and immu-
nized mice were not protected against rotavirus chal-tion sites, both professional antigen presenting cells
(APC) and somatic cells become transfected resulting in lenge. Lack of protection could be due to the absence of
an anti-rotavirus IgA response but, since ip immunizationantigen expression (Condon et al., 1996). Transfected
professional APC are speculated to directly activate T was protective without anti-rotavirus IgA, it is more likely
that rotavirus protein(s) other than, or in addition to, VP6cells, while somatic cells are thought to secrete ex-
pressed antigens or release antigens as a result of cell were required for induction of protective immunity. In
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addition, differences in the methods used in the two par- study in which mice were inoculated with plasmids ex-
pressing VP4 or VP7. Preliminary data indicated that im-enteral immunization protocols (i.e., ip with inactivated
virus versus DNA-based) could also account for the ob- munized mice also generated large humoral IgG re-
sponses to VP4 or VP7, but as in the case of VP6, noserved differences in protection.
Mice immunized by gene gun inoculation developed reduction in shedding of EDIM viral antigen was obtained
in mice immunized with plasmids expressing either VP4extremely high titers of anti-rotavirus IgG (GMT 
3,667,514 U/ml) following EDIM challenge, a GMT that or VP7. Explanation for the lack of agreement between
the results generated by these two laboratories, there-was 14 times greater than their postvaccination titers
and 55 times the postchallenge titers of the unimmunized fore, will require further experimentation.
Because of the conserved nature of group-specific VP6control animals. Thus, DNA-based immunization fol-
lowed by inoculation of live virus generated higher anti- antigens, vaccines that elicit immune responses to this
protein could possibly provide broad protective immunityrotavirus IgG responses than attained by either route
alone. This suggests the possibility that a prime-boost against different serotypes within rotaviruses belonging
to that group. Thus, if immune responses to VP6 canimmunization schedule involving parenteral and oral in-
oculation may also result in much higher immune re- result in protection, this protein remains an attractive
antigen for vaccine development. Because protectionsponses in humans as well as better protection than
attained by either route of immunization alone. has been correlated with anti-rotavirus IgA (McNeal et
al., 1994; Feng et al., 1994), and production of circulatingThe finding reported here that immunized mice inocu-
lated with a plasmid expressing murine EDIM VP6 were anti-VP6 IgA by hybridoma cells injected into mice has
also been associated with protection (Burns et al., 1996),not protected against homologous infection is in agree-
ment with the results reported by some but not all previ- finding methods to stimulate anti-rotavirus IgA following
DNA immunization with VP6 genes may result in protec-ous studies. For example, when adenovirus and vaccinia
virus were used as vectors to deliver VP6 into mice, it tive anti-VP6 responses. Inclusion of immunomodulating
agents in future DNA-based immunization protocols maywas found that the immune responses they generated
did not protect mice against rotavirus infection (Andrews result in stimulation of this isotype.
et al., 1992; Dormitzer et al., 1993). In contrast, a recent
report has provided evidence to show that mice were at ACKNOWLEDGMENT
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